Camelid News and Research

RSS
Immune particles from llama blood could offer protection against several COVID-19 variants

Immune particles from llama blood could offer protection against several COVID-19 variants

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Camelid IFNs could play important role in combating emerging zoonotic pathogens

Camelid IFNs could play important role in combating emerging zoonotic pathogens

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

How to achieve fast, accurate and reliable quantitation of AAV serotypes

How to achieve fast, accurate and reliable quantitation of AAV serotypes

SARS-CoV-2 variants neutralized by camel nanobodies

SARS-CoV-2 variants neutralized by camel nanobodies

The neutralization potential of nanobodies against SARS-CoV-2

The neutralization potential of nanobodies against SARS-CoV-2

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

Camelid nanobody anti-SARS-CoV-2 drug candidates

Camelid nanobody anti-SARS-CoV-2 drug candidates

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Engineering nanobodies to fight against the SARS-CoV-2 virus

Engineering nanobodies to fight against the SARS-CoV-2 virus

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobody inhalation found to be effective against COVID-19 in hamsters

Nanobody inhalation found to be effective against COVID-19 in hamsters

Antibodies generated by malaria cross-react with SARS-CoV-2

Antibodies generated by malaria cross-react with SARS-CoV-2

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy